Neurogranin has been shown to be increased in CSF in Alzheimer’s disease (AD)13 but not in other neurodegenerative conditions such as frontotemporal dementia (FTD), Lewy body disease, Parkinson’s disease (PD), progressive supranuclear palsy and multiple system atrophy14. This evidence concerns the gene NRGN and frontotemporal dementia.